Saturday, April 19, 2025
22.5 C
Bengaluru

Medical Rep and The Future of Work

It is well accepted that pharma field force access to doctors has been decreasing over the years. However, face to face interactions are preferred whenever the doctors think that they add value.

The question then becomes one of how to define value. While different doctors will value different things, this matrix by Deep Bhandari in his webinar, Do Medical Reps Have a Place in the Future of Work? makes it easier to broadbase the definition of value for doctors as a group.

Now the challenge for pharma is do take a hard look at this matrix and work to build the capabilities of their field force to become a Valued Partner.

To know more, do watch the webinar by Deep Bhandari here

Hot this week

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

Rx 2024 – Top 25 Drugs by Sales, Growth & Market Trends

The pharmaceutical market in 2024 saw major shifts driven...

India’s Medical Devices Market: Strategic Implications and Key Investors

KKR's Investments in India's Medical Devices Market: Strategic Implications...

Topics

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

Rx 2024 – Top 25 Drugs by Sales, Growth & Market Trends

The pharmaceutical market in 2024 saw major shifts driven...

India’s Medical Devices Market: Strategic Implications and Key Investors

KKR's Investments in India's Medical Devices Market: Strategic Implications...

Top 25 Indian Pharma Companies by Revenues in 2024

India pharma is crucial for global healthcare, providing affordable...

Top 10 Indian Pharma – 2025

India's top 10 pharma companies by market capitalization, offering insights into...

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

1. Market Overview The oncology sector remains the most dominant...
spot_img

Related Articles

spot_imgspot_img